Phase 1 to Study Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NA-931 in Obese Participants and Patients With Type 2 Diabetes Mellitus
Clinical trial NCT06615700 · COMPLETED
Trial details
- NCT number
- NCT06615700
- Sponsor
- Biomed Industries, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-06
- Primary completion
- 2024-08-12
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.